UN ENSAYO ALEATORIZADO INTERNACIONAL PARA EVALUAR TRATAMIENTOS NO LICENCIADOS PARA COVID-19 EN PACIENTES HOSPITALIZADOS QUE RECIBEN EL TRATAMIENTO CONVENCIONAL PARA COVID QUE SE OFRECE EN CADA HOSPITAL.

Datos básicos

Código:
OMS COVID-19
Protocolo:
OMS COVID-19
EUDRACT:
2020-001366-11
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2020
Año de finalización:
2020
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

MINISTERIO DE SANIDAD, CONSUMO Y BIENESTAR SOCIAL

Resultados del Ensayo Clínico


[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

  • Open Access.

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024


[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

  • Open Access.

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021


A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022


A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022


A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020


A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease.

Orrantia A; (...); Borrego F

Article. 10.1016/j.isci.2020.101298. 2020


A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.

Santos JR; (...); Paredes R

Article. 10.1093/ofid/ofad542. 2023


A survey to describe common practices on antifungal monitoring among Spanish clinicians.

Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel

Article. 10.1016/j.eimc.2021.05.009. 2021


A survey to describe common practices on antifungal monitoring among Spanish clinicians.

Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel

Article. 10.1016/j.eimce.2021.05.020. 2023


Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease: comment on the letter by Garcia-Bustos et al Reply

Garcia-Bustos V; (...); Moral Moral P

Letter. 10.1080/03009742.2020.1756401. 2020


Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021


Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

Tenorio CH; (...); Vallecillos CG

Article. 10.1016/j.ijantimicag.2024.107164. 2024


Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022


Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel

Review. 10.37201/req/018.2024. 2024


Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.

Hidalgo-Tenorio, Carmen; (...); Sadyrbaeva-Dolgova, Svetlana

Article. 10.3390/antibiotics12071218. 2023


Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease

Lozano, Noelia; (...); Osuna, Antonio

Article. 10.1371/journal.pntd.0012356. 2024


Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.

Garcia-Bustos, Victor; (...); Peman, Javier

Article. 10.1016/j.cmi.2023.03.016. 2023


Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain

Ferrer, Ricard; (...); McCann, Eilish

Article. 10.37201/req/096.2021. 2021


Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007. 2023


CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.

Chorão P; (...); Sanz J

Article. 10.1016/j.jtct.2024.01.082. 2024


Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study

Babich, T; (...); Yahav, D

Article. 10.1093/jac/dkab134. 2021


Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.

De La Puerta R; (...); Piñana JL

Article. 10.1038/s41409-021-01319-5. 2021


Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.

Montoro J; (...); Piñana JL

Article. 10.1038/s41409-020-0943-0. 2020


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023


Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].

Monzó-Gallo P; (...); Garcia-Vidal C

Correction. 10.1016/j.ijid.2024.107188. 2024


COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021


CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT

Fragio-Gil, J. J.; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020

  • Open Access.

CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.

Fragío Gil JJ; (...); Román Ivorra JA

Article. 10.1016/j.reumae.2020.08.007. 2022


CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield

Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.reuma.2020.08.002. 2022


Current approach to skin and soft tissue infections. Thinking about continuity of care.

Blanes Hernández R; (...); Salavert Lletí M

Article. 10.37201/req/s01.10.2023. 2023


Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.

Garcia-Bustos, Victor; (...); Blanes, Marino

Article. 10.37201/req/s03.16.2022. 2022


Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.

Vidal-Cortes, Pablo; (...); Zaragoza, Rafael

Review. 10.3390/antibiotics11091160. 2022


Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024


Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.

Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina

Article. 10.1093/mmy/myac038. 2022


Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.

Garcia-Bustos V; (...); Pemán J

Article. 10.1128/Spectrum.00013-21. 2021


Dalbavancin in clinical practice in Spain: a 2 year retrospective study.

Morata, Laura; (...); Almirante, Benito

Article. 10.1093/jacamr/dlac120. 2022


Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.

Morata Ruiz L; (...); Grossi PA

Article. 10.1016/j.jgar.2023.11.015. 2024


Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).

Podzamczer D; (...); Moreno S

Article. 10.1093/ofid/ofab595. 2022


Decalogue for the selection of oral antibiotics for lower respiratory tract infections

Canton, Rafael; (...); Gonzalez del Castillo, Juan

Article. 10.37201/req/172.2021. 2022


Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021


Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024


Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024


Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.

Muñoz Hornero C; (...); Pérez-Elías MJ

Article. 10.1016/j.eimc.2020.05.021. 2021


Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.

Muñoz Hornero C; (...); Pérez-Elías MJ

Article. 10.1016/j.eimce.2021.07.003. 2021


Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.

Asensi Cantó P; (...); Guerreiro M

Article. 10.1111/tid.14067. 2023


Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?

Garcia-Bustos, V; (...); Munoz, EC

Editorial Material. 10.3389/fcimb.2021.671962. 2021


DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).

Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral

Article. 10.3390/v14030524. 2022


Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.

Troya, Jesus; (...); Buzon, Luis

Article. 10.1097/MD.0000000000029252. 2022


Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.

Babich T; (...); Yahav D

Article. 10.1007/s40121-022-00657-1. 2022


Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

Perez Elias MJ; (...); Martinez E

Article. 10.1093/jac/dkaa547. 2021


Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.

Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel

Article. 10.1016/j.clim.2023.109796. 2023


Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.

Gutierrez, Felix; (...); Masia, Mar

Article. 10.1093/cid/ciae359. 2024


Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.

Moreno-Garcia, E; (...); Garcia-Vidal, C

Article. 10.1093/ofid/ofab250. 2021


Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study

Bouza, E; (...); Limon, E

Article. 10.37201/req/135.2020. 2021


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020


Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

Cordero, E; (...); Perez-Romero, P

Article. 10.3389/fimmu.2020.01917. 2020


Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

Corona, Diana; (...); Rivero, Antonio

Article. 10.1016/j.ijantimicag.2023.107016. 2024


Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Santos JR; (...); Paredes R

Article. 10.3389/fcimb.2023.1187999. 2023


Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients

Suarez-Garcia, I.; (...); Jarrin, I.

Meeting Abstract. 2021


Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021


Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

Palacios, R.; (...); Santos, J.

Article. 10.1111/hiv.13489. 2023


eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

Teira, R; (...); Espinosa, N

Article. 10.1080/25787489.2021.1955197. 2021


Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.

Blanes Hernández R, Blanes Juliá M

Article. 10.37201/req/s01.01.2023. 2023


Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.

Fanciulli C; (...); González Garcia J

Article. 10.1111/hiv.13229. 2022


Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020

Lozano, Noelia; (...); Calabuig, Eva

Article. 10.1016/j.actatropica.2024.107458. 2024

  • Open Access.

Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.

Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor

Article. 10.37201/req/s01.20.2022. 2022


Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.

Ruiz-Rodriguez P; (...); Coscolla M

Article. 10.1128/mBio.02315-21. 2021


Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.

Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda

Article. 10.3390/v15071449. 2023


Factors associated with late presentation for HIV care in adolescents in Spain

Epalza, Cristina; (...); Luisa Navarro, Maria

Article. 10.1111/hiv.13407. 2022


Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021


Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

Escudero-Sanchez, Rosa; (...); Cobo Reinoso, Javier

Article. 10.1093/jac/dkac106. 2022


Frequency and characteristics of HTLV in migrants: Results from the +Redivi collaborative network in Spain.

Norman FF; (...); López-Vélez R

Article. 10.1093/jtm/taac019. 2022


Fungal co-infection in COVID-19 patients: Should we be concerned?

Pemán J; (...); Quindós G

Review. 10.1016/j.riam.2020.07.001. 2020


Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024


Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022


Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022


High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022


HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018

Perez-Latorre, L; (...); Gonzalez-Garcia, J

Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021


Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022


Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021


Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella

Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo

Article. 10.1080/22221751.2021.2017756. 2022


How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022


How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria

Article. 10.1016/j.eimc.2024.06.003. 2024


How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

Fernandez-Ruiz, Mario; (...); Abril, Vicente

Article. 10.1016/j.eimce.2024.07.001. 2024


How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

Suarez-Garcia, I; (...); Hernando, V

Article. 10.1186/s12905-021-01370-w. 2021


Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.

Masiá M; (...); Martínez E

Article. 10.1186/s13063-021-05777-6. 2021


Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)

Masia, M.; (...); Martinez, E.

Correction. 10.1186/s13063-023-07655-9. 2023


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

Merchante, N; (...); Pineda, JA

Article. 10.1097/QAD.0000000000002578. 2020


Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020


Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.

Mussini, Cristina; (...); van Wyk, Jean

Article. 10.1007/s10461-024-04490-0. 2024

  • Open Access.

Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.

Chorao, Pedro; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2024.12.006. 2024


Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021


Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015

Perez-Nadales, E; (...); Spanish Fusariosis Study Grp

Article. 10.3201/eid2701.190782. 2021


IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.

Álvarez H; (...); Poveda E

Article. 10.3389/fimmu.2023.1257725. 2023


Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024


Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024


Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007_g. 2023

  • Open Access.

Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez

Article. 10.1016/j.eimc.2023.07.005. 2024


Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.

Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo

Article. 10.1016/j.eimce.2023.07.009. 2023


Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report

Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero

Editorial Material. 10.1016/j.eimc.2024.02.008. 2024

  • Open Access.

Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.

Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta

Case Reports. 10.1016/j.eimce.2024.04.004. 2024


Lack of evidence for infectious SARS-CoV-2 in feces and sewage

Albert, Sandra; (...); Domingo-Calap, Pilar

Article. 10.1007/s10096-021-04304-4. 2021


Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.

Cabanero-Navalon MD; (...); Garcia-Bustos V

Article. 10.3390/biomedicines12102239. 2024


Long or complicated mpox in patients with uncontrolled HIV infection.

Corma-Gómez A; (...); Macías J

Article. 10.1002/jmv.29511. 2024


Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy

Martinez-Camprecios, J; (...); Buti, M

Meeting Abstract. 2021


Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.

Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ

Article. 10.1016/j.biopha.2023.114587. 2023


Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023


Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Correction. 10.1016/j.kint.2024.10.002. 2024

  • Open Access.

Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Article. 10.1016/j.kint.2024.04.010. 2024


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022


Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021


Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


Mitral repair results in endocarditis

Dominguez-Massa, C; (...); Montero-Argudo, JA

Article. 10.1016/j.circv.2020.08.005. 2020

  • Open Access.

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021


Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.

Bernardino, Jose I.; (...); Rodes, Berta

Article. 10.3390/microorganisms11071818. 2023


Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.

Berzosa Sánchez A; (...); Ramos Amador JT

Article. 10.1097/INF.0000000000003009. 2021


Mucormycosis: Current and future management perspective

Gomez, MTM, Lleti, MS

Article. 10.1016/j.riam.2021.04.003. 2021


Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors

Martin-Mateos, Rosa; (...); Albillos, Agustin

Meeting Abstract. 2022


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

Martin-Mateos R; (...); Albillos A

Article. 10.1016/j.jhep.2024.02.023. 2024


Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021


National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021


National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

  • Open Access.

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024


Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.

Moral Moral, Pedro; (...); Salavert Lleti, Miguel

Article. 10.37201/req/s03.14.2022. 2022


Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022


ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023


Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023


OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024


Papel de cefditoreno en el tratamiento de las infecciones comunitarias de piel y tejidos blandos: revisando la evidencia.

Cabañero-Navalón MD, García-Bustos V, Salavert Lletí M

Review. 10.37201/req/063.2021. 2021


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

  • Open Access.

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021


Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021


Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021


Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

  • Open Access.

Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.

Llibre, Josep M; (...); Alcantara, Felipe Rodriguez

Article. 10.1111/hiv.13650. 2024


Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

Casadellà M; (...); Noguera-Julian M

Article. 10.1093/jac/dkaa349. 2020


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021


Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.

Garcia-Bustos V; (...); Lletí MS

Article. 10.1038/s41598-021-90949-2. 2021


Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).

Valencia ME; (...); González J

Article. 10.1016/j.eimce.2024.05.005. 2024


Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey

Garriga, C; (...); Rodriguez-Arenas, MA

Article. 10.1136/ebmental-2019-300138. 2020


Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

Teira, Ramon; (...); Berenguer, Juan

Article. 10.1371/journal.pone.0249515. 2021


Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.

Escudero-Sánchez R; (...); Cobo J

Article. 10.1007/s15010-020-01567-5. 2021


Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.

Hernando V; (...); CoRIS-HIV Biobank

Article. 10.1080/23744235.2021.1893377. 2021


Recommendations for antibiotic selection for severe nosocomial infections

Mensa, Josep; (...); Soriano, Alex

Article. 10.37201/req/126.2021. 2021


Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.

Los-Arcos I; (...); Ruiz-Camps I

Review. 10.1007/s15010-020-01521-5. 2020


Recommendations on the use of azole antifungals in hematology-oncology patients

Azanza, Jose Ramon; (...); Gutierrez, Carlos Duenas

Review. 10.37201/req/013.2023. 2023


Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies

Javier Candel, Francisco; (...); Cuervo Pinto, Rafael

Review. 10.37201/req/023.2023. 2023


Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.

Garcillan, Beatriz; (...); Diaz-Castroverde, Sabela

Article. 10.3390/vaccines10020297. 2022


Rickettsioses imported by travellers and migrants to Spain attended in the+Redivi network, 2009-2020.

Llenas-Garcia, Jara; (...); Perez-Molina, Jose A.

Article. 10.1093/jtm/taad050. 2023


Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

Salto-Alejandre, S; (...); Cordero, E

Article. 10.1371/journal.pone.0250796. 2021


Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.

Merchante, Nicolas; (...); Merino, Esperanza

Article. 10.1093/jacamr/dlad033. 2023


Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina

Article. 10.1016/j.ijid.2024.107070. 2024


Safety and Tolerability of More than Six Days of Tedizolid Treatment

Vendrell, MM; (...); Viladomiu, AS

Article. 10.1128/AAC.00356-20. 2020


SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

Esteve-Sanchez, Yoel; (...); Climent, Estela

Article. 10.1016/j.snb.2024.136378. 2024


SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

Lopez-Palacios, Alba; (...); Climent, Estela

Article. 10.1016/j.snr.2025.100298. 2025


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020


Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.

Collazos J; (...); Asensi V

Article. 10.1016/j.ijid.2021.01.044. 2021


Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Teira, Ramon; (...); Curran, Adria

Article. 10.1007/s40121-022-00630-y. 2022


SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022


Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis

Podzamczer, D.; (...); Rivero, A.

Meeting Abstract. 2023


Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Podzamczer, Daniel; (...); Rivero, Antonio

Article. 10.1093/jac/dkad285. 2023


Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022


Tedizolid: new data and experiences for clinical practice.

Salavert Lleti, M; (...); Cabanero-Navalon, M D

Article. 10.37201/req/s01.06.2021. 2021


Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Serrano, Leyre

Article. 10.3390/jcm12216864. 2023


Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.3390/jcm12206526. 2023


The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022


The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022


The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.

Hidalgo-Tenorio C; (...); Martínez-Martínez L

Article. 10.1007/s40265-024-02102-8. 2024


The positioning of ceftobiprole in Staphylococcus aureus bacteremia.

Membrillo de Novales FJ; (...); Hidalgo-Tenorio C

Article. 10.1093/cid/ciae123. 2024


The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.1186/s13054-024-05224-3. 2024


The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

  • Open Access.

Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.

Alonso-Navarro, Rodrigo; (...); Soriano, Alex

Article. 10.1186/s12879-023-08222-y. 2023


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020


Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.

Vinuela, Laura; (...); Garcia, Federico

Article. 10.1002/jmv.29287. 2023


Tratamiento y prevención de la viruela del mono.

de la Calle-Prieto F; (...); Membrillo FJ

Article. 10.1016/j.eimc.2022.08.001. 2022


Treatment and prevention of monkeypox

Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS

Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023

  • Open Access.

Treatment and prevention of monkeypox.

de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier

Article. 10.1016/j.eimce.2022.12.010. 2023


Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).

Alkaissy Y; (...); Perez-Molina JA

Article. 10.1093/jtm/taae067. 2024


Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).

Norman, Francesca F.; (...); Perez-Molina, Jose A.

Article. 10.1093/jtm/taac083. 2022


Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.

Ruiz-Alguero, Marta; (...); Jarrin, Inma

Article. 10.1111/hiv.13469. 2023


Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.

Lozano N; (...); Osuna A

Article. 10.1371/journal.pone.0282814. 2023


VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023


Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients

Gil, JJF; (...); Ivorra, JAR

Article. 10.1016/j.medcli.2019.12.029. 2020


What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.

Garcia-Bustos V; (...); Pemán J

Article. 10.3390/microorganisms9102177. 2021


Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection

de Medrano, VAL, de Lucas, EM, Lleti, MS

Letter. 10.1016/j.rce.2020.04.004. 2020


Campos de estudio

Compartir